US 12,421,531 B2
Transaminase mutant and use thereof
Hao Hong, Morrisville, NC (US); Gage James, Morrisville, NC (US); Yi Xiao, Tianjin (CN); Fang Liu, Tianjin (CN); Na Zhang, Tianjin (CN); Zujian Wang, Tianjin (CN); Junjie Yan, Tianjin (CN); Wanming Shi, Tianjin (CN); Mujiao Zhang, Tianjin (CN); and Ye Liu, Tianjin (CN)
Assigned to ASYMCHEM LABORATORIES (FUXIN) CO., LTD., Liaoning (CN)
Appl. No. 17/755,266
Filed by ASYMCHEM LABORATORIES (FUXIN) CO., LTD., Liaoning (CN)
PCT Filed Oct. 25, 2019, PCT No. PCT/CN2019/113430
§ 371(c)(1), (2) Date Apr. 25, 2022,
PCT Pub. No. WO2021/077425, PCT Pub. Date Apr. 29, 2021.
Prior Publication US 2022/0380817 A1, Dec. 1, 2022
Int. Cl. C12P 13/00 (2006.01); C12N 1/20 (2006.01); C12N 1/21 (2006.01); C12N 9/10 (2006.01); C12N 15/70 (2006.01); C12R 1/19 (2006.01)
CPC C12P 13/001 (2013.01) [C12N 1/205 (2021.05); C12N 9/1096 (2013.01); C12N 15/70 (2013.01); C12Y 206/01 (2013.01); C12N 2800/101 (2013.01); C12R 2001/19 (2021.05)] 20 Claims
 
1. A transaminase mutant comprising an amino acid sequence having 80% identity with SEQ ID NO: 1 and mutations H70T+V77G.